secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001493152-24-020909
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity raises $645,455 in third closing of Series B Preferred; total $2M private placement
--------------------------------------------------------------------------------

- Issued 71 shares of Series B Convertible Preferred to Ionic Ventures for $645,455 on May 15, 2024.
- Combined with prior closings, total 220 Series B shares sold for $2M gross proceeds.
- Filed amendment to Form S-3 to register 2,095,238 common shares issuable upon conversion.
- Side letter waives 30-day limit on additional closings; company must deliver CA good-standing certificate within 10 days.
- Stockholder approval required if conversions exceed Nasdaq rules; meeting to be held within 75 days of triggering event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224020909/0001493152-24-020909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224020909/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer